Evidence map›Paper›PMID 27129202›Full record

ArticleThe Journal of biological chemistry2016

Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins.

Paulo H C Godoi, Rachel P Wilkie-Grantham, Asami Hishiki, Renata Sano, Yasuko Matsuzawa, Hiroko Yanagi, Claudia E Munte, Ya Chen, Yong Yao, Francesca M Marassi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Paulo H C GodoiSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Rachel P Wilkie-GranthamSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Asami HishikiSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Renata SanoSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Yasuko MatsuzawaSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Hiroko YanagiSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Claudia E MunteInstitute of Biophysics and Physical Biochemistry, University of Regensburg, Universitätsstr. 31, 93040 Regensburg, Germany.
Ya ChenSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Yong YaoSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Francesca M MarassiSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Hans R KalbitzerInstitute of Biophysics and Physical Biochemistry, University of Regensburg, Universitätsstr. 31, 93040 Regensburg, Germany.
Shu-Ichi MatsuzawaSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037,. Electronic address: smatsuzawa@sbpdiscovery.org.
John C ReedSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037,; Roche, Pharma Research and Early Development, Basel 4070, Switzerland. Electronic address: John_C.Reed@roche.com.
Discovery Institute · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Regensburg · DERoche (Switzerland) · CH

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
THE THERAPY OF AMLP01CA055164 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI THOMAS, MATTIE J · 1992 to 2011
$25.3M
Molecular mechanism of BCL2-dependent apoptosisR01CA179087 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HANEIN, DORIT, MARASSI, FRANCESCA M · 2014 to 2018
$3.6M
Virulence Mechanisms of Viral Bcl-2 HomologsR01AI091967 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MATSUZAWA, SHU-ICHI · 2011 to 2015
$2.4M
CA-81543NCI NIH HHS P01 CA055164NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA179087NIAID NIH HHS R01 AI091967
6 · The paper itself

Abstract

B cell lymphoma gene 2 (Bcl-2) family proteins are key regulators of programmed cell death and important targets for drug discovery. Pro-apoptotic and anti-apoptotic Bcl-2 family proteins reciprocally modulate their activities in large part through protein interactions involving a motif known as BH3 (Bcl-2 homology 3). Nur77 is an orphan member of the nuclear receptor family that lacks a BH3 domain but nevertheless binds certain anti-apoptotic Bcl-2 family proteins (Bcl-2, Bfl-1, and Bcl-B), modulating their effects on apoptosis and autophagy. We used a combination of NMR spectroscopy-based methods, mutagenesis, and functional studies to define the interaction site of a Nur77 peptide on anti-apoptotic Bcl-2 family proteins and reveal a novel interaction surface. Nur77 binds adjacent to the BH3 peptide-binding crevice, suggesting the possibility of cross-talk between these discrete binding sites. Mutagenesis of residues lining the identified interaction site on Bcl-B negated the interaction with Nur77 protein in cells and prevented Nur77-mediated modulation of apoptosis and autophagy. The findings establish a new protein interaction site with the potential to modulate the apoptosis and autophagy mechanisms governed by Bcl-2 family proteins.

Indexed as

HumansNuclear Receptor Subfamily 4, Group A, Member 1Protein BindingProto-Oncogene Proteins c-bcl-2NR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1Proto-Oncogene Proteins c-bcl-2apoptosisautophagyB cell lymphoma 2 (Bcl-2) familyBcl-bBfl-1NMRNR4A1Nur77protein-protein interaction

Identifiers

PMID27129202
PMCPMC4933167
OpenAlexW2342300845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.